Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-α production in rat mesangial cell cultures

Experimental Nephrology

Volumn 5, Issue 1, 1997, Pages 100-104

  Leithäuser, Malte L ^a   Rob, Peter M ^a   Sack, Klaus ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

cyclosporine A; endotoxin; glomerular mesangium; pentoxifylline; taurolidine; tumor necrosis factor

Indexed keywords

CYCLOSPORIN A; ENDOTOXIN; PENTOXIFYLLINE; TAUROLIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; CELLS, CULTURED; CYCLOSPORINE; ENDOTOXINS; GLOMERULAR MESANGIUM; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; MALE; PENTOXIFYLLINE; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; THIADIAZINES; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 0031049527     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 1993;43:252-267.
2. Wardle EN: Endotoxaemia and acute renal failure. Care Crit Med 1992;8:23-27.
3. Baud L, Oudinet J-P, Bens M, Noe L, Peraldi M-N, Rondeau E, Etienne J, Ardaillou R: Production of tumor necrosis factor by rat mesangial cells in response to lipopolysaccharide. Kidney Int 1989;35:1111-1118.
4. Egido J, Gomez-Chiarri M, Ortiz A, Bustos C, Alonso J, Gomez-Guerrero C, Gomez-Garre D, Lopez MJ, Plaza J, Gonzalez E: Role of tumor necrosis factor-α in the pathogenesis of glomerular diseases. Kidney Int 1993;43:S59-S64.
5. Medina J, Baud L, Garcia Escribano C, Gila JA, Rodriguez Puyol D, Rodriguez Puyol M: Tumor necrosis factor-induced contraction of cultured rat mesangial cells: Interaction with angiotensin II. J Lab Clin Med 1993;122:164-172.
6. Pfeilschifter J, Rob P, Mülsch A, Fandrey J, Vosbeck K, Busse R: Interleukin-1β and tumor necrosis factor-α induce a macrophage-type of nitric oxide synthase in rat mesangial cells. Eur J Biochem 1992;203:251-255.
7. 2 production is synergistically increased in human mesangial cells by combination of IL-1 and tumor necrosis factor-α. J Immunol 1989;143: 1989-1995.
8. Meulders Q, He CJ, Adida C, Peraldi MN, Schleuning WD, Sraer JD, Rondeau E: Tumor necrosis factor-α increases antifibrinolytic activity of cultured human mesangial cells. Kidney Int 1992;42:327-334.
9. Cotran RS, Pober JS: Effects of cytokines on vascular endothelium: Their role in vascular and immune injury. Kidney Int 1989;35:969-975.
10. Goldfeld AE, Flemington EK, Boussiotis VA, Theodos CM, Titus RG, Strominger JL, Speck SH: Transcription of the tumor necrosis factor-α gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK 506 in human B cells. Proc Natl Acad Sci USA 1992;89:12198-12201.
11. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shephard HM, Palladino MA: Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J Exp Med 1987;166:571-576.
12. Zabel P, Schade FU, Schlaak M: Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993;187:447-463.
13. Bedrosian I, Sofia RD, Wolff SM, Dinarello CA: Taurolidine, an analogue of the amino acid taurine, suppresses interleukin-1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine 1991;3: 568-575.
14. Little D, Regan M, Keane RM, Bouchier-Hayes D: Perioperative immune modulation. Surgery 1993;114:87-92.
15. Pfirrmann RW, Leslie GB: The antiendotoxin activity of taurolin in experimental animals. J Appl Bacteriol 1979;46:97-101.
16. Willats SM, Radford S, Leitermann M: Effect of the antiendotoxin agent, taurolidine, in the treatment of sepsis syndrome: A placebo-controlled, double-blind trial. Crit Care Med 1995; 23:1033-1039.
17. Ohnishi ST, Barr JK: A simplified method of quantitating protein using the biuret and phenol reagents. Anal Biochem 1978;86:193-200.
18. Feist W, Ulmer AJ, Musehold J, Brade H, Kusumoto S, Flad HD: Induction of tumor necrosis factor-alpha by lipopolysaccharide partial structures. Immunobiology 1989;179: 293-307.
19. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
20. Abbott F, Tam FWK, Ryan JJ, Rees AJ: Human mesangial cells synthesize interleukin-1α but not interleukin-1β, interleukin-1 receptor antagonist, or tumor necrosis factor. Nephrol Dial Transplant 1992;7:997-1001.
21. Baud L, Ardaillou R: Tumor necrosis factor-alpha in glomerular injury. Kidney Int 1994; 45:S32-S36.
22. Ren K, Van Liew JB, Noble B: The effect of cyclosporin A on disease progression in proliferative immune complex glomerulonephritis. Clin Immunol Immunopathol 1993;66:107-113.
23. Risler T, Braun N, Erley C, Müller GA: Behandlung der primären Glomerulonephritiden mit nephrotischem Syndrom. Nieren Hochdruckkr 1993;22:S5-S8.
24. Guerrero-Romero F, Rodriguez-Moran M, Paniagua-Sierra JR, Garcia-Bulnes G, Salas-Ramirez M, Amato D: Pentoxifylline reduces proteinuria in insulin-dependent and noninsulin-dependent diabetic patients. Clin Nephrol 1995;43:116-121.
25. Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-α, IL-1β, and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-692.
26. Fouqueray B, Philippe C, Herbelin A, Perez A, Ardaillou R, Baud L: Cytokine formation within rat glomeruli during experimental endotoxemia. J Am Soc Nephrol 1993;3:1783-1791.
27. Kita T, Tanaka N, Nagano T: The immunocytochemical localisation of tumor necrosis factor and leucotriene in the rat kidney after treatment with lipopolysaccharide. Int J Exp Pathol 1993;74:471-477.